Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.19.2
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock
Common Stock Subscribed but unissued
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning of the period at Sep. 30, 2017 $ 149,943 $ 0 $ 31,580,022 $ (29,503,446) $ 2,226,519
Balance at the beginning of the period (in shares) at Sep. 30, 2017 149,942,857        
Net loss/Income $ 0 0 0 (3,378,825) (3,378,825)
Subscribed but unissued common stock and warrants 0 2,137,546 (80,000) 0 2,057,546
Issuance of restricted stock $ 233 0 (233) 0 0
Issuance of restricted stock (in shares) 233,000        
Stock based compensation expense $ 0 0 1,282,052 0 1,282,052
Shares issued for the exercise of warrants $ 242 0 63,146 0 63,388
Shares issued for the exercise of warrants (in shares) 242,273        
Shares issued for the exercise of stock options - cashless $ 117 0 (117) 0 0
Shares issued for the exercise of stock options - cashless (in shares) 116,883        
Balance at the ending of the period at Jun. 30, 2018 $ 150,535 2,137,546 32,844,870 (32,882,271) 2,250,680
Balance at the ending of the period (in shares) at Jun. 30, 2018 150,535,013        
Balance at the beginning of the period at Mar. 31, 2018 $ 150,302 0 32,593,935 (30,669,631) 2,074,606
Balance at the beginning of the period (in shares) at Mar. 31, 2018 150,302,013        
Net loss/Income $ 0 0 0 (2,212,640) (2,212,640)
Subscribed but unissued common stock and warrants 0 2,137,546 (80,000) 0 2,057,546
Issuance of restricted stock $ 233 0 (233) 0 0
Issuance of restricted stock (in shares) 233,000        
Stock based compensation expense $ 0 0 331,168 0 331,168
Balance at the ending of the period at Jun. 30, 2018 $ 150,535 2,137,546 32,844,870 (32,882,271) 2,250,680
Balance at the ending of the period (in shares) at Jun. 30, 2018 150,535,013        
Balance at the beginning of the period at Sep. 30, 2018 $ 159,815 0 35,517,491 (34,317,478) $ 1,359,828
Balance at the beginning of the period (in shares) at Sep. 30, 2018 159,815,013       164,297,013
Net loss/Income $ 0 0 0 (3,719,437) $ (3,719,437)
Issuance of restricted stock $ 3,517 0 (3,517) 0 0
Issuance of restricted stock (in shares) 3,517,000        
Stock based compensation expense $ 0 0 1,042,285 0 1,042,285
Issuance of common stock and warrants, net of financing costs $ 8,615 0 1,083,272 0 1,091,887
Issuance of common stock and warrants, net of financing costs (in shares) 8,615,384        
Shares issued for the exercise of stock options - cashless $ 477 0 (477) 0 0
Shares issued for the exercise of stock options - cashless (in shares) 477,269        
Shares issued for the exercise of stock options $ 88 0 32,312 0 $ 32,400
Shares issued for the exercise of stock options (in shares) 87,567       1,525,000
Issuance of restricted stock for services $ 50 0 21,450 0 $ 21,500
Issuance of restricted stock for services (in shares) 50,000        
Balance at the ending of the period at Jun. 30, 2019 $ 172,562 0 37,692,816 (38,036,915) $ (171,537)
Balance at the ending of the period (in shares) at Jun. 30, 2019 172,562,233       173,577,233
Balance at the beginning of the period at Mar. 31, 2019 $ 163,947 0 36,382,873 (36,747,753) $ (200,933)
Balance at the beginning of the period (in shares) at Mar. 31, 2019 163,946,849        
Net loss/Income $ 0 0 0 (1,289,162) (1,289,162)
Stock based compensation expense 0 0 226,671 0 226,671
Issuance of common stock and warrants, net of financing costs $ 8,615 0 1,083,272 0 1,091,887
Issuance of common stock and warrants, net of financing costs (in shares) 8,615,384        
Balance at the ending of the period at Jun. 30, 2019 $ 172,562 $ 0 $ 37,692,816 $ (38,036,915) $ (171,537)
Balance at the ending of the period (in shares) at Jun. 30, 2019 172,562,233       173,577,233